These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 3986978)

  • 1. Lipoprotein predictors of the severity of coronary artery disease in men and women.
    Reardon MF; Nestel PJ; Craig IH; Harper RW
    Circulation; 1985 May; 71(5):881-8. PubMed ID: 3986978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of angiographically defined coronary artery disease to serum lipoproteins and apolipoproteins in young survivors of myocardial infarction.
    Hamsten A; Walldius G; Szamosi A; Dahlen G; de Faire U
    Circulation; 1986 Jun; 73(6):1097-110. PubMed ID: 3698244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
    Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
    Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation of plasma levels and composition of apolipoprotein B-containing lipoproteins to angiographically defined coronary artery disease in young patients with myocardial infarction.
    Tornvall P; Båvenholm P; Landou C; de Faire U; Hamsten A
    Circulation; 1993 Nov; 88(5 Pt 1):2180-9. PubMed ID: 8222113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association of increased levels of intermediate-density lipoproteins with smoking and with coronary artery disease.
    Steiner G; Schwartz L; Shumak S; Poapst M
    Circulation; 1987 Jan; 75(1):124-30. PubMed ID: 3791598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events.
    Phillips NR; Waters D; Havel RJ
    Circulation; 1993 Dec; 88(6):2762-70. PubMed ID: 8252689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of fluvastatin on intermediate density lipoprotein (remnants) and other lipoprotein levels in hypercholesterolemia.
    Broyles FE; Walden CE; Hunninghake DB; Hill-Williams D; Knopp RH
    Am J Cardiol; 1995 Jul; 76(2):129A-135A. PubMed ID: 7604788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein and apolipoprotein levels in angiographically defined coronary atherosclerosis.
    Schmidt SB; Wasserman AG; Muesing RA; Schlesselman SE; Larosa JC; Ross AM
    Am J Cardiol; 1985 Jun; 55(13 Pt 1):1459-62. PubMed ID: 3923814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atherogenicity of triglyceride-rich lipoproteins.
    Krauss RM
    Am J Cardiol; 1998 Feb; 81(4A):13B-17B. PubMed ID: 9526808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of lipoproteins, apolipoproteins, triglycerides and lipid ratios to plasma total cholesterol in young adults: the CARDIA Study. Coronary Artery Risk Development in Young Adults.
    Iribarren C; Belcher JD; Jacobs DR; Gross MD; Schreiner PJ; Sidney S
    J Cardiovasc Risk; 1996 Aug; 3(4):391-6. PubMed ID: 8946271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The severity of coronary atherosclerosis in type 2 diabetes mellitus is related to the number of circulating triglyceride-rich lipoprotein particles.
    Tkác I; Kimball BP; Lewis G; Uffelman K; Steiner G
    Arterioscler Thromb Vasc Biol; 1997 Dec; 17(12):3633-8. PubMed ID: 9437215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-density lipoprotein size and subclasses are markers of clinically apparent and non-apparent atherosclerosis in type 2 diabetes.
    Berneis K; Jeanneret C; Muser J; Felix B; Miserez AR
    Metabolism; 2005 Feb; 54(2):227-34. PubMed ID: 15690318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study.
    Sharrett AR; Ballantyne CM; Coady SA; Heiss G; Sorlie PD; Catellier D; Patsch W;
    Circulation; 2001 Sep; 104(10):1108-13. PubMed ID: 11535564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum lipoproteins and apolipoproteins in young normocholesterolaemic, non-diabetic Indian men with myocardial infarction.
    Sewdarsen M; Desai RK; Vythilingum S; Shah N; Rajput MC
    Postgrad Med J; 1991 Feb; 67(784):159-64. PubMed ID: 2041847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intermediate-density lipoprotein and cholesterol-rich very low density lipoprotein in angiographically determined coronary artery disease.
    Tatami R; Mabuchi H; Ueda K; Ueda R; Haba T; Kametani T; Ito S; Koizumi J; Ohta M; Miyamoto S; Nakayama A; Kanaya H; Oiwake H; Genda A; Takeda R
    Circulation; 1981 Dec; 64(6):1174-84. PubMed ID: 7296792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intermediate-density lipoproteins and progression of carotid arterial wall intima-media thickness.
    Hodis HN; Mack WJ; Dunn M; Liu C; Liu C; Selzer RH; Krauss RM
    Circulation; 1997 Apr; 95(8):2022-6. PubMed ID: 9133510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationale for use of non-high-density lipoprotein cholesterol rather than low-density lipoprotein cholesterol as a tool for lipoprotein cholesterol screening and assessment of risk and therapy.
    Frost PH; Havel RJ
    Am J Cardiol; 1998 Feb; 81(4A):26B-31B. PubMed ID: 9526810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of lipoprotein cholesterol and triglycerides with the severity of coronary artery disease in men and women.
    Korhonen T; Savolainen MJ; Koistinen MJ; Ikäheimo M; Linnaluoto MK; Kervinen K; Kesäniemi YA
    Atherosclerosis; 1996 Dec; 127(2):213-20. PubMed ID: 9125311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atherogenic lipoprotein profile in families with and without history of early myocardial infarction.
    Dobiásová M; Raslová K; Rauchová H; Vohnout B; Ptácková K; Frohlich J
    Physiol Res; 2001; 50(1):1-8. PubMed ID: 11300220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRL, IDL, and LDL apolipoprotein B-100 and HDL apolipoprotein A-I kinetics as a function of age and menopausal status.
    Matthan NR; Jalbert SM; Lamon-Fava S; Dolnikowski GG; Welty FK; Barrett HR; Schaefer EJ; Lichtenstein AH
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1691-6. PubMed ID: 15933247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.